Lytix Biopharma AS Announces the Addition of Nobel Laureate Dr James Allison and Oncologist Dr Padmanee Sharma From the MD Anderson Cancer Center to its SAB and as Company Strategic Advisors

His research elucidated the mechanism behind T cell activation and pioneered the first immune checkpoint blocker drug for the treatment of cancer.